The Assessment of Multiplex PCR in Identifying Bacterial Infections in Patients Hospitalized with SARS-CoV-2 Infection: A Systematic Review
- PMID: 36978332
- PMCID: PMC10044563
- DOI: 10.3390/antibiotics12030465
The Assessment of Multiplex PCR in Identifying Bacterial Infections in Patients Hospitalized with SARS-CoV-2 Infection: A Systematic Review
Abstract
Bacterial infection can occur in patients hospitalized with SARS-CoV-2 in various conditions, resulting in poorer outcomes, such as a higher death rate. This current systematic review was conducted in order to assess the efficiency of multiplex PCR in detecting bacterial infections in hospitalized COVID-19 patients, as well as to analyze the most common bacterial pathogens and other factors that interfere with this diagnosis. The research was conducted using four electronic databases (PubMed, Taylor&Francis, Web of Science, and Wiley Online Library). Out of 290 studies, nine were included in the systematic review. The results supported the use of multiplex PCR in detecting bacteria, considering its high sensitivity and specificity rates. The most common bacterial pathogens found were Klebsiella pneumoniae, Staphylococcus aureus, Pseudomonas aeruginosa, Streptococcus pneumoniae, and Haemophilus influenzae. The median age at admission was 61.5 years, and the majority of patients were men (70.3%), out of a total of 1553 patients. The proportion of ICU admission was very high, with a pooled proportion of 52.6% over the analyzed studies, and an average duration of hospitalization of 13 days. The mortality rate was proportionally high, as was the rate of ICU admission, with a pooled mortality of 24.9%. It was discovered that 65.2% of all patients used antibiotics before admission, with or without medical prescription. Antibiotic treatment should be considered consciously, considering the high risks of developing antibiotic resistance.
Keywords: COVID-19; SARS-CoV-2; bacterial infection; co-infection; multiplex PCR.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- World Health Organization. [(accessed on 23 December 2022)]. Available online: https://covid19.who.int.
-
- Citu C., Gorun F., Motoc A., Ratiu A., Gorun O.M., Burlea B., Neagoe O., Citu I.M., Rosca O., Bratosin F., et al. Evaluation and Comparison of the Predictive Value of 4C Mortality Score, NEWS, and CURB-65 in Poor Outcomes in COVID-19 Patients: A Retrospective Study from a Single Center in Romania. Diagnostics. 2022;12:703. doi: 10.3390/diagnostics12030703. - DOI - PMC - PubMed
-
- Pilut C.N., Citu C., Gorun F., Bratosin F., Gorun O.M., Burlea B., Citu I.M., Grigoras M.L., Manolescu D., Gluhovschi A. The Utility of Laboratory Parameters for Cardiac Inflammation in Heart Failure Patients Hospitalized with SARS-CoV-2 Infection. Diagnostics. 2022;12:824. doi: 10.3390/diagnostics12040824. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
